Explore All 1514 Add-on Acquisition Chemicals Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 2, 2026 |
| Target | Cooley Group |
| Sector | Chemicals |
| Buyer(s) | Michelin |
| Sellers(s) | J.H. Whitney Capital Partners |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1863 |
| Sector | Automotive |
| Revenue | 27.2B EUR (2024) |
Michelin is a manufacturer and marketer of tires for every type of vehicle, including airplanes, automobiles, bicycles/motorcycles, earthmovers, farm equipment and trucks. It also offers electronic mobility support services on ViaMichelin.com and publishes travel guides, hotel and restaurant guides, maps and road atlases. Michelin was founded in 1863 and is based in Clermont-Ferrand, France.
| Deal Context for Buyer | # |
|---|---|
| Overall | 21 of 21 |
| Sector: Chemicals | 1 of 1 |
| Type: Add-on Acquisition | 16 of 16 |
| State: Rhode Island | 1 of 1 |
| Country: United States | 4 of 4 |
| Year: 2026 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-06 |
Michelin - Midigama Tyre Division and Casting Product Division
Sri Lanka Michelin's Midigama Tyre Division and Casting Product Division provide bias tires and tracks for compact construction equipment. Michelin's Midigama Tyre Division and Casting Product Division are based in Sri Lanka. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1946 |
| PE ASSETS | 1.0B USD |
| Size | Large |
| Type | Sector Agnostic |
J.H. Whitney Capital Partners is a private equity firm focused on small and middle-market buyouts and recapitalizations of US-based, growth-oriented companies. The Firm targets companies with $50 to $500 million in revenue and looks to invest $20 to $125 million per transaction. Industries of interest include consumer, healthcare, specialty manufacturing, and business services. J.H. Whitney Capital Partners was formed in 1946 and is based in New Canaan, Connecticut.
| Deal Context for Seller | # |
|---|---|
| Overall | 30 of 30 |
| Sector: Chemicals | 1 of 1 |
| Type: Add-on Acquisition | 9 of 9 |
| State: Rhode Island | 1 of 1 |
| Country: United States | 29 of 29 |
| Year: 2026 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-06-09 |
Caris Life Sciences
Irving, Texas, United States Caris Life Sciences is a biosciences company focused on developing and delivering innovative molecular diagnostic, prognostic and theranostic services. As an innovative biotechnology company, Caris is actively working to fulfill the promise of precision medicine through transformative platforms to help patients with cancer and other complex diseases. Caris Life Sciences was founded in 2008 and is based in Irving, Texas. |
Sell | - |
